Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Huxley N"" wg kryterium: Autor


Wyświetlanie 1-5 z 5
Tytuł :
The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
Autorzy :
Kang YJ; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Killen J; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Caruana M; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Simms K; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Taylor N; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Frayling IM; Institute of Medical Genetics, University Hospital of Wales, Cardiff, United Kingdom.; Institute of Cancer and Genetics, Cardiff University, Cardiff, United Kingdom.
Snowsill T; University of Exeter Medical School, Exeter, United Kingdom.
Huxley N; Centre for Health Economics, Monash Business School, Monash University, Melbourne, VIC.
Coupe VM; Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands.
Hughes S; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Freeman V; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.
Boussioutas A; University of Melbourne, Melbourne, VIC.; Royal Melbourne Hospital, Melbourne, VIC.
Trainer AH; Parkville Familial Cancer Centre, Peter MacCallum Cancer Institute, Melbourne, VIC.
Ward RL; University of Sydney, Sydney, NSW.; University of New South Wales, Sydney, NSW.
Mitchell G; Parkville Familial Cancer Centre, Peter MacCallum Cancer Institute, Melbourne, VIC.
Macrae FA; Royal Melbourne Hospital, Melbourne, VIC.
Canfell K; Cancer Research Division, Cancer Council New South Wales, Sydney, NSW.; University of Sydney, Sydney, NSW.; University of New South Wales, Sydney, NSW.
Pokaż więcej
Źródło :
The Medical journal of Australia [Med J Aust] 2020 Feb; Vol. 212 (2), pp. 72-81. Date of Electronic Publication: 2019 Oct 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Colonoscopy/*statistics & numerical data
Colorectal Neoplasms, Hereditary Nonpolyposis/*diagnosis
Cost-Benefit Analysis/*statistics & numerical data
Genetic Testing/*economics
Aged ; Australia/epidemiology ; Colonoscopy/economics ; Colorectal Neoplasms, Hereditary Nonpolyposis/economics ; Colorectal Neoplasms, Hereditary Nonpolyposis/mortality ; Female ; Humans ; Immunohistochemistry/economics ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England.
Autorzy :
Tikhonova IA; Peninsula Technology Assessment Group (PenTAG), University of Exeter, South Cloisters 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK. .
Huxley N; Monash University, Melbourne, VIC, Australia.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, South Cloisters 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK.
Crathorne L; Roboleo Ltd, York, UK.
Varley-Campbell J; Peninsula Technology Assessment Group (PenTAG), University of Exeter, South Cloisters 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK.
Napier M; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter, South Cloisters 3.09, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK.
Pokaż więcej
Źródło :
PharmacoEconomics [Pharmacoeconomics] 2018 Jul; Vol. 36 (7), pp. 837-851.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*economics
Camptothecin/*analogs & derivatives
Cetuximab/*economics
Colonic Neoplasms/*economics
Colorectal Neoplasms/*economics
Cost-Benefit Analysis/*statistics & numerical data
Panitumumab/*economics
Antibodies, Monoclonal, Humanized/economics ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Camptothecin/economics ; Camptothecin/therapeutic use ; Cetuximab/therapeutic use ; Colonic Neoplasms/drug therapy ; Colonic Neoplasms/genetics ; Colonic Neoplasms/secondary ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/secondary ; Female ; Fluorouracil/economics ; Fluorouracil/therapeutic use ; Humans ; Leucovorin/economics ; Leucovorin/therapeutic use ; Male ; Middle Aged ; Models, Economic ; Organoplatinum Compounds/economics ; Organoplatinum Compounds/therapeutic use ; Panitumumab/therapeutic use ; Proto-Oncogene Proteins p21(ras)/genetics ; Quality-Adjusted Life Years ; Randomized Controlled Trials as Topic/statistics & numerical data ; Survival Analysis
SCR Protocol :
Folfox protocol; IFL protocol
Czasopismo naukowe
Tytuł :
Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
Autorzy :
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Briscoe S; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Frayling IM; Institute of Cancer and Genetics, University Hospital of Wales, Cardiff, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2017 Sep; Vol. 21 (51), pp. 1-238.
Typ publikacji :
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :
Cost-Benefit Analysis*
Genetic Testing*/economics
Genetic Testing*/methods
Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics
Colorectal Neoplasms, Hereditary Nonpolyposis/economics ; DNA Mismatch Repair ; Endometrial Neoplasms ; England ; Female ; Humans ; Microsatellite Instability ; Quality-Adjusted Life Years
Czasopismo naukowe
Tytuł :
The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.
Autorzy :
Crathorne L; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Haasova M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Briscoe S; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Long L; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Medina-Lara A; University of Exeter Medical School, Exeter, UK.
Mujica-Mota R; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Napier M; Royal Devon and Exeter Hospital, Exeter, UK.
Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Pokaż więcej
Źródło :
Health technology assessment (Winchester, England) [Health Technol Assess] 2016 Feb; Vol. 20 (13), pp. 1-588, v-vi.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms :
Cost-Benefit Analysis*
Technology Assessment, Biomedical*
Anemia/*drug therapy
Hematinics/*therapeutic use
Neoplasms/*drug therapy
Anemia/economics ; Anemia/etiology ; Hematinics/economics ; Humans ; Models, Economic ; Neoplasms/economics ; Quality-Adjusted Life Years
Czasopismo naukowe
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies